Dual involvement of protein kinase C delta in apoptosis induced by syndecan-2 in osteoblasts

Armelle Orosco1, Olivia Fromigué, Eric Haÿ

  • 1Laboratory of Osteoblast Biology and Pathology, INSERM, Lariboisière Hospital, University Paris 7, Paris, France.

Insights

Syndecan-2 (SYND2) regulates osteoblastic cell apoptosis by modulating protein kinase C delta (PKCdelta). SYND2 decreases PKCdelta activity, promoting osteoblast survival, but also increases PKCdelta levels, which can induce apoptosis.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Biochemistry

Background:

  • Syndecans are proteoglycans involved in cell signaling.
  • Syndecan-2 (SYND2) has been previously linked to osteoblastic (OB) cell apoptosis.
  • The precise mechanisms by which SYND2 influences OB cell fate remain under investigation.

Purpose of the Study:

  • To elucidate the novel functional interaction between syndecan-2 (SYND2) and protein kinase C delta (PKCdelta) in osteoblasts.
  • To determine the role of PKCdelta in SYND2-mediated osteoblastic cell apoptosis.
  • To understand how SYND2 modulates PKCdelta activity and its downstream effects.

Main Methods:

  • Overexpression of SYND2 in MG63 OB cells.
  • Analysis of PKCdelta protein and mRNA levels.
  • Assessment of PKCdelta subcellular localization and phosphorylation status.
  • In vitro kinase assays using histone as a substrate.
  • Inhibition of PKCdelta using Rottlerin or dominant-negative constructs.
  • Rescue experiments with PKCdelta catalytic domain (CAT) construct.
  • siRNA-mediated knockdown of PKCdelta.

Main Results:

  • SYND2 overexpression increased cytosolic PKCdelta protein levels without altering mRNA.
  • SYND2 reduced PKCdelta activity by decreasing phosphorylation at threonine 505.
  • PKCdelta acts as a pro-survival kinase; its inhibition increased OB cell apoptosis.
  • SYND2-induced apoptosis was dependent on PKCdelta accumulation and required PKCdelta's pro-apoptotic function.
  • Overexpression of wild-type PKCdelta induced osteoblast apoptosis.

Conclusions:

  • SYND2 inhibits the anti-apoptotic function of PKCdelta through modulation of its activity.
  • SYND2 promotes osteoblast apoptosis by increasing PKCdelta protein levels, potentially activating a pro-apoptotic pathway.
  • A complex interplay exists where SYND2 can both inhibit PKCdelta activity and promote its pro-apoptotic role, depending on cellular context and protein levels.

Related Concept Videos

The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
Caspases01:24

Caspases

Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside cells.
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Assembly of Signaling Complexes01:30

Assembly of Signaling Complexes

Multiprotein signaling complexes are formed in a dynamic process involving protein-protein interactions at the cytoplasmic domain of transmembrane receptors or enzymatic and non-enzymatic proteins associated with the receptor. These complexes ensure the activation and propagation of intracellular signals that regulate cell functions.
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...